According to a new report, published by KBV research, The Global Cough Remedies Market size is expected to reach $12.8 billion by 2030, rising at a market growth of 5.3% CAGR during the forecast period.
The Adult segment is leading the Global Cough Remedies Market by Age in 2022 thereby, achieving a market value of $9.0 billion by 2030. In comparison to infants, chronic respiratory conditions such as asthma and COPD are more prevalent in the adult population. These individuals may require long-term management of cough symptoms and prefer cough remedies that provide sustained relief and address underlying inflammation or airway obstruction. Hence, these factors can assist in the growth of the segment.
The Online Pharmacies segment is anticipated to have a CAGR of 6.3% during (2023 - 2030). The convenience and accessibility offered by online shopping platforms have increasingly driven consumers to purchase cough remedies and other healthcare products online. The proliferation of online shopping has been facilitated by several factors, including the availability of a broad range of products for purchase, the capability to compare prices, and the insight customers provide through reviews. Thus, these aspects will boost the demand in the segment.
The Expectorants segment is registering a strong potential in the Global Cough Remedies Market by Type in 2022 thereby, achieving a market value of $4.5 billion by 2030. Expectorants are available in various formulations, including syrups, tablets, capsules, and effervescent powders, catering to different consumer preferences and needs. Liquid formulations are particularly popular among children and individuals with swallowing difficulties, while tablets and capsules offer convenience and portability for on-the-go use. Hence, these aspects will boost the demand in the segment.
The Tablets & Pills segment is poised to have a CAGR of 5.1% during (2023 - 2030). The effectiveness of tablets/pills in providing symptom relief for cough conditions plays a significant role in driving consumer choice and demand within this segment. Products with fast-acting formulations or targeted relief for specific cough symptoms may gain preference among consumers. Therefore, the segment will expand rapidly in the coming years.
Full Report: https://www.kbvresearch.com/cough-remedies-market/
The North America region dominated the Global Cough Remedies Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $5.0 billion by 2030. The Europe region is exhibiting a CAGR of 5.1% during (2023 - 2030). Additionally, The Asia Pacific market would experience a CAGR of 6% during (2023 - 2030).
By Age
By Distribution Channel
By Type
By Dosage
By Geography
Unique Offerings 
